| 1 |
25306426 | Effect of niacin on lipids and glucose in patients with type 2 diabetes: A meta-analysis of randomized, controlled clinical trials. | 2015 Oct |
1 |
| 2 |
25708866 | A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography. | 2015 May |
1 |
| 3 |
26409460 | Low-density-lipoprotein cholesterol concentrations and risk of incident diabetes: epidemiological and genetic insights from the Framingham Heart Study. | 2015 Dec |
4 |
| 4 |
24855368 | Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia. | 2014 |
1 |
| 5 |
23948546 | Niacin, an old drug with a new twist. | 2013 Oct |
2 |
| 6 |
22400810 | Extended-release niacin/laropiprant effects on lipoprotein subfractions in patients with type 2 diabetes mellitus. | 2012 Aug |
2 |
| 7 |
21392609 | The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: impact on Global Health outcomes (AIM-HIGH) trial. | 2011 Mar |
1 |
| 8 |
21474895 | Important considerations for treatment with dietary supplement versus prescription niacin products. | 2011 Mar |
3 |
| 9 |
21593473 | Rationale for aggressive lipid lowering in high-risk patients. | 2011 Apr |
1 |
| 10 |
20686417 | What does the future hold for niacin as a treatment for hyperlipidaemia and cardiovascular disease? | 2010 Nov |
2 |
| 11 |
20855072 | Optimal pharmacologic approach to patients with hypertriglyceridemia and low high-density lipoprotein-cholesterol: randomized comparison of fenofibrate 160 mg and niacin 1500 mg. | 2010 Nov |
1 |
| 12 |
19192988 | Perspectives on low-density lipoprotein cholesterol goal achievement. | 2009 Feb |
1 |
| 13 |
18928015 | Molecule of the Month. TREDAPTIVE (nicotinic acid/laropiprant): a new lipid-modifying therapy for the treatment of LDL-C, HDL-C and triglycerides. | 2008 |
1 |
| 14 |
17697054 | Dyslipidaemia in diabetic patients: time for a rethink. | 2007 Sep |
1 |
| 15 |
17853726 | [Treatment of low HDL-cholesterol levels in the reduction of cardiovascular risk]. | 2007 Mar-Apr |
1 |
| 16 |
15834527 | [Niacin--an additive therapeutic approach for optimizing lipid profile]. | 2005 Apr 15 |
1 |
| 17 |
16400392 | [Pharmacology of niacin or nicotinic acid]. | 2005 Oct |
1 |
| 18 |
15324528 | Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C. | 2004 Aug |
1 |
| 19 |
8333817 | Combination drug therapy for hypercholesterolemia. The trade-off between cost and simplicity. | 1993 Aug 9 |
1 |